Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Der Nephrologe|February 3, 2021
[COVID-19 and renal transplantation]Florina Regele, Rainer Oberbauer
Journal of Medical Virology|March 21, 2024
The kinetics of Torque Teno virus plasma load following calcineurin inhibitor dose change in kidney transplant recipientsFlorina Regele, Frederik Haupenthal, Konstantin Doberer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 26, 2018
Regression of left atrial diameter after kidney transplantation is associated with prolonged survival: an observational studyFlorina Regele, Alexander Kainz, Michael Kammer, et al.
Frontiers in Medicine|March 9, 2026
A kidney transplant recipient with shingles and necrotizing bacterial superinfection: a case reportAnna Garstenauer, Raffael Scharinger, Christof Aigner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetesFlorina Regele, Kira Jelencsics, Dov Shiffman, et al.
Biomedicines|November 11, 2022
Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic TestingWolfgang Winnicki, Andreas Fichtenbaum, Goran Mitulovič, et al.
Frontiers in Medicine|June 27, 2022
Stopping of Mycophenolic Acid in Kidney Transplant Recipients for 2 Weeks Peri-Vaccination Does Not Increase Response to SARS-CoV-2 Vaccination-A Non-randomized, Controlled Pilot StudyFlorina Regele, Andreas Heinzel, Karin Hu, et al.
Frontiers in Medicine|October 27, 2022
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Frontiers in Medicine|August 8, 2022
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled TrialAndreas Heinzel, Eva Schrezenmeier, Florina Regele, et al.
Ebiomedicine|October 23, 2024
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants-a prospective cohort study (RESCUE-TX)Roman Reindl-Schwaighofer, Andreas Heinzel, Lukas Raab, et al.
Pageof 2